Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-27

Clinical Trial Update: Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on insulin lispro in participants with inadequately controlled Type 2 diabetes, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • insulin lispro (insulin lispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2014-02-27